IAC Pre-Congress One day Tutorial

Dr. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital/Cornell University in New York with fellowships in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital in Baltimore.

Known globally as an innovative educator, Dr. Ali has over 350 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.

Dr. Ali has published extensively with over 320 peer-reviewed articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” (now in its 3rd edition) has been translated in 8 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and has served as member of the executive board and chair of the scientific program and several other committees of the American Society of Cytopathology (ASC). He is a past-President of the ASC, President-elect of the International Academy of Cytology (IAC) and chair of the International Board of Cytopathology of the IAC. He is a fellow of both, the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, “President’s Award” in 2012, “Excellence in Education Award” in 2015, the IAC’s “Maurice Goldblatt Award” in 2019 and Papanicolaou Society of Cytopathology’s “LC Tao Educator of the Year Award” in 2022.

Dr. Baloch received his medical degree from Liaquat Medical University in Sind, Pakistan. After receiving his PhD in 1991 he joined the pathology residency at Hahnemann University Hospital. This was followed by fellowships in surgical pathology at Memorial Sloan Kettering Cancer Center, New York and cytopathology at the University of Pennsylvania Medical Center, Philadelphia. Dr. Baloch began his career as an assistant professor in the Department of Pathology & Laboratory Medicine at UPENN medical center in1997 and is currently a professor of pathology and laboratory medicine there. He has authored more than 200 peer reviewed publications in leading pathology journals on the subject of endocrine and head and neck pathology; and book chapters and monographs. Dr. Baloch has delivered numerous lectures, workshops and short courses both at the national and international meetings including ASC, USCAP, ASCP, CAP, ECC and IAP. Dr. Baloch has co-authored 3 books and has served as co-editor of the most recent ?Milan System for Reporting Salivary Gland Cytopathology?. Dr. Baloch has also served as the chair of the terminology and morphologic criteria committee of the 2007 NCI sponsored thyroid FNA initiative which led to the development of ?Bethesda Thyroid FNA Classification Scheme?. Dr. Baloch also served on the international panel which recommended the renaming of encapsulated follicular variant of papillary thyroid carcinoma to non-invasive follicular tumor with papillary like nuclear features (NIFTP). Dr. Baloch is executive editor of Diagnostic Cytopathology and member of the editorial board of Cancer Cytopathology, Cytojournal, Endocrine Pathology and Journal of American Society of Cytopathology.

Dr. Baloch has served as the chair of ASCP and ASC annual meeting scientific program committee, member of USCAP education committee, ASC executive board, ASCP committee for continuing professional development, Papanicolaou Society scientific program committee, American Association of Endocrinologist thyroid nodule guideline task force and American Thyroid Association laboratory test committee.

Prof. Lukas Bubendorf is a surgical pathologist and head of cytopathology at the Institute for Pathology of the University Hospital Basel. He completed a post-doctoral research fellowship at the National Human Genome Research Institutes at the NIH, Bethesda, from 1998-2000.

He is a member of numerous national and international scientific societies, the Steering Committee of the ETOP Lungscape project, the IASLC Pathology Committee and the editorial boards of several journals including Journal of Thoracic Oncology, Lung Cancer, Pathobiology, Cancer Cytopathology, Diagnostic Cytopathology, and Acta Cytologica.

Professor Bubendorf is the author of more than 250 papers in peer-reviewed journals and several book chapters. His major interests and diagnostic expertise lie within lung pathology and uropathology, and in the general field of cytopathology. His research group currently investigates the role of genomic evolution and heterogeneity in solid tumors, including lung cancer and prostate cancer. In cytology, he aims at translating molecular techniques and assays to clinical routine application.

Dr Ashish Chandra MD FRCPath DipRCPath (Cytol), MIAC, Vice-President IAC, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom. He is a co-editor of the International system for reporting serous fluid cytopathology and is a contributor to other terminology systems and clinical guidelines. His interests include FNA, ROSE and genito-urinary histopathology.

Dr. Engels is Head of Cytopathology of the Institute of Pathology of the University Hospital Cologne, Germany since 2011.

Dr. Engels received her medical degree in Aachen / Germany in 1984. She completed training in internal medicine and in hematology/medical oncology and passed the International Board of Cytopathology Examination in 1999. She started to work in clinical cytology in 1992 and practiced cytology in the context of a busy hematology/oncology unit. 2009 she joined the Institute of Pathology of the University Hospital Bonn and changed to the University Hospital Cologne two years later.

Her main fields of interest include lung cytology and cytology of serous fluids. She is co-author of The International System for Serous Fluid Cytopathology and an expert member of the IAC-IARC-WHO Joint Editorial Board for the WHO Reporting System for Lung Cytopathology.

She’s member of the editorial boards of Acta Cytologica and Cytopathology and reviewer for several journals. She has been serving the German Society of Cytology as president and is now secretary general. She’s effective member of the EFCS (European Federation of Cytology Societies) and chair of the Educational Committee of the EFCS. She has received the 2021 Maurice Goldblatt Award of the IAC.

Dr. Engels has been teaching cytology since many years. She’s organizing an annual cytology tutorial in Cologne. She has given numerous lectures and workshops in Germany and abroad.

23.06.2023

Dr. Lozano graduated and obtained PhD in Medicine and Surgery from the University of Navarra. She specialized in Pathology at the University Clinic of Navarra (CUN). Dr. Lozano completed a postdoctoral stay at the University of Nebraska Medical Center, in the Department of Pathology and Microbiology (March 1993-April 1995). Currently, Dr. Lozano is director of the Department of Pathology of the Clínica Universidad de Navarra, Pamplona, and Head of cytopathology and molecular pathology in cytology. Dr. Lozano is Associate Professor of Pathology at Medical School of the University of Navarra. She is the Past President of the Spanish Society of Cytopathology, and the President-Elect of the Spanish Society of Pathology

Active member of SEAP (Sociedad Española de Anatomía Patológica), SEC (Sociedad Española de Citología), ESP (European Society of Pathology and Member of the Cytopathology Working group), ASC American Society of Cytopathology , IAC (International Academy of Cytology). Member of the expert panel for biomarker guidelines of the Spanish Societies of Pathology and Medical Oncology (SEOM).

Member of Editorial boards of Several journals

As researcher, Dr. Lozano is part of multidisciplinary teams within the university itself, as well as national and international levels. She has special dedication to lung and pancreas cytopathology as well as great interest and extensive experience in new approaches of FNAB and the development and application of molecular techniques in cytological samples and small samples by obtaining material using minimally invasive methods. She is deeply involved in the study of tumor microenvironment in lung and pancreatic tumors. She dedicates also to surgical pathology of Lung and Mediastinum.

Dr. Lozano has written more than 190 articles in national and international scientific journals. She has presented more than 400 communications to meetings, more than 200 lectures given, as well as several courses on FNA and molecular biology applied to cytopathology.

Donna Russell is a graduate of the State University of New York ? Upstate Medical Center in Syracuse, NY and has been an employee at the University of Rochester Medical Center for over 35 years. She received her Master?s in Education from the University of Rochester Graduate School of Education and currently is the Education Coordinator of the Cytopathology Resident/Fellow Training program at the University of Rochester. She also is the Program Director of the Roswell Park Comprehensive Cancer Center/Daemen College School of Cytotechnology. She currently is educating the eighth class from this Master’s level program in cytology.

Donna is an active member of numerous cytology organizations. Her special interests are in gynecologic, cell block preparation, ROSE and telecytology. She has published book chapters and many manuscripts in all areas of cytology. Donna has played an active role in teaching within the IAC, ECC, ASC, ASCP, ASCT and CAP. She has presenting numerous workshops, panel luncheons, and teleconferences in diagnostic cytopathology and related topics.

Dr Tse is a professor in the Department of Anatomical and Cellular Pathology, Prince of Wales Hospital and the Chinese University of Hong Kong. He is the vice president for Asia for IAP, and the president of the Hong Kong Division of International Academy of Pathology. He is currently the Regional Editor for Australasia for Histopathology, section editor for Diagnostic Pathology, associate editor for Pathology, editorial advisory board member for Cancer Cytopathology, overseas editor for Journal of the American Society of Cytopathology, outreach editor for Cytopathology, and editorial board member for other journals including Acta Cytologica, Chinese Pathology Journal, Modern Pathology and Seminars in Diagnostic Pathology. Dr. Tse has given many invited presentations, convened regional and international meetings and has published actively in breast pathology, and has published extensively.

Danijela Vrdoljak-Mozetič graduated from The Faculty of Medicine of the University of Rijeka, Croatia in 1991. In 1996 she became a Specialist in Clinical Cytology. She is working in Clinical Hospital Centre Rijeka, currently at the position of the Head of Department of Pathology and Cytology. As assistant professor she participates in teaching pathology and cytology at the Faculty of Medicine of the University of Rijeka. She is a member of the Working groups for specialist training in pathology and cytology, national programme for cervical screening and guidelines. From 2014-2021 she was the president of Croatian Society for Clinical Cytology of Croatian Medical Association. Since 2018 she was the chair of Educational Committee of the European Federation of Cytology Societies (EFCS), and in 2021 she became EFCS Secretary General. She has published more than forty papers and participated in many conferences. Special fields of interest: gynaecological cytology, cervical screening, HPV testing, endometrial cytology, vulvar and anal cytology, ovarian cytology, head and neck, effusion, pulmonary and urinary cytology, education in cytopathology.